Similar articles

• Tamiflu: "a nice little earner".

  Jack A. Jack A. BMJ. 2014 Apr 9;348:g2524. doi: 10.1136/bmj.g2524. BMJ. 2014. PMID: 24811410 No abstract available.
• Current evidence shows no place for antiviral drug distribution in a flu pandemic.

  Saunders PJ, Middleton J. Saunders PJ, et al. BMJ. 2014 Apr 29;348:g2955. doi: 10.1136/bmj.g2955. BMJ. 2014. PMID: 24781318 No abstract available.
• Antiviral agents: to treat or not to treat? An old dilemma revisited in light of new data from the 2009 influenza A(H1N1) pandemic.

  Hernández JM, López-Rodas V, Costas E. Hernández JM, et al. J Clin Virol. 2010 Oct;49(2):145-6. doi: 10.1016/j.jcv.2010.07.001. Epub 2010 Aug 2. J Clin Virol. 2010. PMID: 20674477 No abstract available.
• [Influenza A, pregnancy and neuraminidase inhibitors].

  Montané E, Lecumberri J, Pedro-Botet ML. Montané E, et al. Med Clin (Barc). 2011 May 28;136(15):688-93. doi: 10.1016/j.medcli.2010.02.006. Epub 2010 Apr 22. Med Clin (Barc). 2011. PMID: 20416906 Review. Spanish.
• Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1.

  Renaud C, Kuypers J, Englund JA. Renaud C, et al. J Clin Virol. 2011 Oct;52(2):70-8. doi: 10.1016/j.jcv.2011.05.019. Epub 2011 Jun 17. J Clin Virol. 2011. PMID: 21684202 Review.